Seattle Genetics

SGEN

SGEN
Seattle Genetics Stock Quote
$74.01 $1.23 1.7%
BATS BZX Real Time Price as of September 20, 2019, 4:00 p.m. EDT View Interactive SGEN Charts

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

News & Analysis: Seattle Genetics

The Fool has written over 200 articles on Seattle Genetics.

All

Market Moves

Earnings











Interactive Chart